KAISA CAPITAL (00936) releases its interim performance, with a net profit of HK$4.46 million for the period, representing a year-on-year increase of 5.09%.
Jiayuanjie Capital (00936) releases interim performance for the six months ending June 30, 2025, with sustained operation...
Kaisa Capital (00936) released its interim financial results for the six months ending on June 30, 2025. The revenue from continuing operations was HK$118 million, an increase of 5.88% year-on-year. During the period, the net profit was HK$4.46 million, an increase of 5.09% year-on-year. The basic earnings per share was HK$0.421.
Related Articles

ZIBUYU (02420) announces its interim results, with a net profit attributable to shareholders of approximately 1.06 billion yuan, an increase of 15.9% year-on-year.

SIS INT'L (00529) releases interim results, with a net profit attributable to shareholders of HK$91.41 million, representing a year-on-year increase of 173.92%.
.png)
CH NETCOMTECH (08071) announced its interim financial results, with a net loss of HK$3.872 million attributable to shareholders, representing a 13.82% increase compared to the same period last year.
ZIBUYU (02420) announces its interim results, with a net profit attributable to shareholders of approximately 1.06 billion yuan, an increase of 15.9% year-on-year.

SIS INT'L (00529) releases interim results, with a net profit attributable to shareholders of HK$91.41 million, representing a year-on-year increase of 173.92%.

CH NETCOMTECH (08071) announced its interim financial results, with a net loss of HK$3.872 million attributable to shareholders, representing a 13.82% increase compared to the same period last year.
.png)
RECOMMEND

Analysts Respond to Trump’s Dismissal of Fed Governor Cook as a Further Assault on Central Bank Independence
26/08/2025

U.S. Proposes Including Copper, Silicon, Silver on 2025 Critical Minerals List Amid Supply Chain Concerns
26/08/2025

Trump Vows to Slash U.S. Drug Prices by Up to 1500%, Triggering Sell-Off in Pharma Stocks
26/08/2025